Opinion

Video

Setting Goals for Pediatric Atopic Dermatitis Treatment

Panelists discuss the goals of treating atopic dermatitis, focusing on symptom control and quality of life, with treatment differing for children and adults, and emphasize using assessment tools such as Eczema Area and Severity Index (EASI)-75/90, Investigator Global Assessment (IGA), and itch scores alongside patient-reported outcomes to guide decisions while also considering disease severity and the impact of atopic comorbidities in treatment approaches

Video content above is prompted by the following:

1. What are the goals of treatment for a patient with atopic dermatitis?
a. How do treatment goals differ for atopic dermatitis in the pediatric population compared with adults?
b. How do you leverage standard assessment tools such as EASI-75/90, IGA, and itch scores vs patient- and caregiver-reported outcomes?
2. When considering disease severity and a treatment approach, how do you determine systemic eligibility in a pediatric patient?
3. Does the presentation of atopic comorbidities dictate a treatment approach?

Related Videos
Safety Profile, Accessibility of Tapinarof Cream for Atopic Dermatitis, with Adelaide Hebert, MD
Impact of Tapinarof Cream Approval for Atopic Dermatitis, with Adelaide Hebert, MD
Sobia Laique, MD | Credit: Cleveland Clinic
Sobia Laique, MD | Credit: Cleveland Clinic
What is the Global Lung Function Initiative and Its Purpose for Lung Function Testing?
Greg A. Sachs, MD I Credit: Regenstrief Institute
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.